Cataract Treatment Gets More Precise with FDA Approval of Softec HD™ Lens
New Intraocular Lens (IOL) Implant from Lenstec Enables Surgeons to Achieve Unmatched Precision and Predictability St. Petersburg, Florida – April 6, 2010 — Lenstec, Inc. — a manufacturer of technologically-advanced implantable lenses – today announced that the U.S. Food and Drug Administration has approved the company’s Softec HD™ Intraocular Lens Implant (IOL) for treating patients with … [read more]
Lenstec Gains FDA Approval for Softec HD™ IOL to Treat Cataracts
New Intraocular Lens Implant Enables Surgeons to Achieve Unmatched Precision and Predictability St. Petersburg, Florida – April 5, 2010 — Lenstec, Inc. — a provider of technologically- advanced implantable lenses – today announced that the U.S. Food and Drug Administration has approved the company’s Softec HD™ Intraocular Lens Implant (IOL) for treating patients with cataracts. The … [read more]